Macrogenics reported $-41304000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Amgen AMGN:US $ 1317M 159M
AstraZeneca AZN:LN 29568.96M 177.38M
Biogen BIIB:US $ 1058M 754.2M
Bristol Myers Squibb BMY:US $ 1421M 143M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Daiichi Sankyo 4568:JP Y 18852M 46197M
Eli Lilly And LLY:US $ 952.5M 950.4M
Epizyme EPZM:US $ -35.74M 19.76M
Genmab GEN:DC DK 1891M 1426M
Geron GERN:US $ -28.12M 1.98M
Gilead Sciences GILD:US $ 1144M 1125M
Immunogen IMGN:US $ -62.02M 37.88M
Johnson & Johnson JNJ:US $ 4814M 335M
Karyopharm Therapeutics KPTI:US $ -49062000 7.66M
Macrogenics MGNX:US $ -41.3M 25.14M
Merk MRK:US $ 3944M 366M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Pfizer PFE:US $ 9905M 2042M
Puma Biotechnology PBYI:US $ 9.37M 12.77M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Seattle Genetics SGEN:US $ -134.83M 1.67M
Xencor XNCR:US $ -33.98M 57.57M